Strata Critical Medical, Inc.
$4.52
▼
-0.72%
2026-04-21 09:36:00
www.stratacritical.com
NCM: SRTA
Explore Strata Critical Medical, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$397.54 M
Current Price
$4.52
52W High / Low
$6.02 / $2.51
Stock P/E
9.61
Book Value
$4.18
Dividend Yield
—
ROCE
-7.31%
ROE
-8.01%
Face Value
—
EPS
$-0.24
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Care Facilities
Employees
327
Beta
2.11
Debt / Equity
1.19
Current Ratio
6.38
Quick Ratio
6.38
Forward P/E
—
Price / Sales
1.78
Enterprise Value
$293.51 M
EV / EBITDA
-51.41
EV / Revenue
1.49
Rating
None
Target Price
$8.81
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Net margin remains healthy.
Cons
- Capital efficiency is modest.
- Operating margin is thin.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Basel Medical Group Ltd | $0.62 | — | $10.73 M | — | -25.54% | -1.64% | $9.4 / $0.49 | $0.23 |
| 2. | Astrana Health, Inc. | $31.45 | 69.19 | $1.56 B | 0.51% | 4.9% | 4.49% | $34.8 / $18.08 | $15.94 |
| 3. | DaVita Inc. | $149.93 | 15.78 | $10.02 B | — | 14.02% | 64.85% | $159.42 / $101 | $-9.5 |
| 4. | InnovAge Holding Corp. | $7.95 | 172.72 | $1.12 B | — | -4.46% | 1.18% | $10.69 / $2.6 | $1.89 |
| 5. | Enhabit, Inc. | $13.72 | — | $702.56 M | — | 6.13% | -0.46% | $14.22 / $6.47 | $10.53 |
| 6. | NewGenIvf Group Limited | $2.19 | 0.08 | $1.32 M | — | -135.35% | 79.4% | $7,356 / $1.52 | $110.5 |
| 7. | Acadia Healthcare Company, Inc. | $27.84 | — | $2.56 B | — | 7.76% | -40.96% | $28.48 / $11.43 | $21.55 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 66.79 M | 49.3 M | 70.8 M | 54.31 M | 54.36 M | — |
| Operating Profit | -6.41 M | -5.62 M | -4.95 M | -7.58 M | -8.37 M | — |
| Net Profit | -8.83 M | 57.42 M | -3.74 M | -3.49 M | -9.79 M | — |
| EPS in Rs | -0.1 | 0.66 | -0.04 | -0.04 | -0.11 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 197.14 M | 146.82 M | 225.18 M | 146.12 M |
| Operating Profit | -22.35 M | -22.52 M | -68.12 M | -53.53 M |
| Net Profit | 41.35 M | -27.31 M | -56.08 M | -27.26 M |
| EPS in Rs | 0.48 | -0.31 | -0.64 | -0.31 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 325.47 M | 256.68 M | 294.94 M | 325.02 M |
| Total Liabilities | 46.4 M | 34.74 M | 60.64 M | 50.54 M |
| Equity | 279.07 M | 221.94 M | 234.3 M | 274.49 M |
| Current Assets | 126.19 M | 160.74 M | 206.26 M | 218.13 M |
| Current Liabilities | 19.79 M | 22.73 M | 35.49 M | 26.61 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -48.91 M | -2.52 M | -32.35 M | -37.13 M |
| Investing CF | 69.75 M | -1.02 M | 17.09 M | 79.34 M |
| Financing CF | -8.91 M | -5.76 M | -0.08 M | -1.08 M |
| Free CF | -59.92 M | -35.5 M | -34.46 M | -37.86 M |
| Capex | -11.01 M | -32.98 M | -2.11 M | -0.73 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -34.8% | 54.11% | — | — |
| Earnings Growth % | 51.3% | -105.71% | — | — |
| Profit Margin % | -18.6% | -24.9% | -18.66% | — |
| Operating Margin % | -15.34% | -30.25% | -36.63% | — |
| Gross Margin % | 20.15% | 18.71% | 15.24% | — |
| EBITDA Margin % | -11.28% | -27.09% | -32.72% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.